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The striatum is critically involved in motor and motivational functions. The dorsal striatum,
caudate–putamen, is primarily implicated in motor control and the learning of habits and
skills, whereas the ventral striatum, the nucleus accumbens, is essential for motivation and
drug reinforcement.The GABA medium-sized spiny neurons (MSNs, about 95% of striatal
neurons), which are targets of the cerebral cortex and the midbrain dopaminergic neurons,
form two pathways. The dopamine D1 receptor-positive (D1R) striatonigral MSNs project
to the medial globus pallidus and substantia nigra pars reticulata (direct pathway) and
co-express D1R and substance P, whereas dopamine D2 receptor-positive (D2R) striatopal-
lidal MSNs project to the lateral globus pallidus (indirect pathway) and co-express D2R,
adenosine A2A receptor (A2AR) and enkephalin (Enk). The speciﬁc role of the two effer-
ent pathways in motor and motivational control remained poorly understood until recently.
Indeed, D1R striatonigral and D2R striatopallidal neurons, are intermingled and morpho-
logically indistinguishable, and, hence, cannot be functionally dissociated with techniques
such as chemical lesions or surgery. In view of the still debated respective functions of
projection D2R striatopallidal and D1R striatonigral neurons and striatal interneurons, both
in motor control and learning but also in more cognitive processes such as motivation, the
present review sum up the development of new models and techniques (bacterial artiﬁcial
chromosome transgenesis, optogenetic, viral transgenesis) allowing the selective target-
ing of these striatal neuronal populations in adult animal brain to understand their speciﬁc
roles.
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INTRODUCTION
The striatum represents the main input nucleus of the basal
ganglia, a system of subcortical nuclei critically involved in
motor control and motivational processes and altered in sev-
eral conditions such as Parkinson’s and Huntington’s diseases or
drug addiction and schizophrenia (Nestler, 2005; Graybiel, 2008;
Kreitzer and Malenka, 2008). The projection neurons of the stria-
tum are GABAergic (γ-aminobutyric acid) medium-sized spiny
neurons (MSNs), which account for the large majority of stri-
atal neurons (95% in rodents; Tepper et al., 2007). The MSNs are
subdivided into two subpopulations that form two main efferent
pathways. The striatonigral MSNs mainly project to the entope-
duncular nucleus (EP or medial globus pallidus) and substantia
nigra pars reticulata SNr (direct pathway) and express dopamine
D1 receptor (D1R, drd1a), M4 muscarinic acetylcholine receptor
(chrm4) and substance P neuropeptide (SP) whereas striatopal-
lidal MSNs mostly project to the lateral globus pallidus (LGP;
indirect pathway) and co-express dopamine D2 receptor (D2R,
drd2), adenosineA2A receptor (A2AR) and enkephalin (Enk;Young
and Bonner, 1986; Gerfen et al., 1990; Graybiel, 1990; Schiffmann
and Vanderhaegen, 1993). Striatal interneurons, which account
for a small proportion of striatal neurons (2–3% in rodent and
possibly up to 20% in primates; Tepper and Bolam, 2004), are
phenotypically diverse and consist of four different populations:
one cholinergic and three GABAergic. The cholinergic interneu-
rons are giant aspiny neurons (with a somatic diameter that can
be in excess of 40μm) expressing the choline acetyltransferase
(ChAT; Kawaguchi et al., 1995). The three subtypes of GABAergic
interneurons can be distinguished neurochemically: two express
either the calcium binding protein parvalbumin or calretinin, and
one co-expresses the peptides somatostatin and neuropeptideY
(NPY) aswell as the enzymeneuronal nitric oxide synthase (nNOS;
Tepper and Bolam, 2004). Based on the origin of cortical gluta-
matergic and midbrain dopaminergic (DA) afferents, the striatum
can be functionally divided into dorsal and ventral subregions.
The dorsal striatum is thought to be involved mostly in motor
behaviors, while ventral striatum (or nucleus accumbens, NAc)
is crucial for motivational processes (Robbins and Everitt, 1996;
Groenewegen, 2003; Nestler, 2005).
The striatal neurons are mosaically distributed through all the
striatum (Bolam et al., 2000) and cannot be targeted with tech-
niques such as electrolysis or surgery. Selective modulations of
striatal subpopulation activity by drugs remains difﬁcult since
most of pharmacological agents have multiple targets widely dis-
tributed in the brain. Moreover, striatal MSNs are similar in
number, in size, and shape. Because of these technical limitations,
the deciphering of striatum cell-type speciﬁc functions remained
unsatisfactory for decades. In this paper, we will review the differ-
ent strategies developed to target intrinsic striatal neuronal sub-
types, with an emphasis on the most recent state of the art genetic
tools and the major functional processes illuminated in these
models.
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FIRST EXPERIMENTAL TOOLS TO TARGET STRIATAL
SUBPOPULATIONS
Because striatal neuronal types differ one from each other notably
according to their gene expression pattern, expression of a par-
ticular gene can lead to selective susceptibility to a given phar-
macological agent. Then, initial approaches attempting to target
neuronal population in the striatum consisted in using toxic com-
poundwith a relative speciﬁcity for a neuronal subtype inwildtype
animals. For instance, stereotaxic injection of the aziridinium ion
of ethylcholine (AF64A; Mantione et al., 1981) in the rat stria-
tum led to a desired and expected decrease in ChAT activity
but with a concomitant loss of glutamate decarboxylase (GAD)
and tyrosine hydroxylase (TH) activities (Sandberg et al., 1984),
suggesting a toxic effect against striatal cholinergic neurons as
well as other neuronal populations. Intraventricular administra-
tion of an immunotoxin composed of a monoclonal antibody
directed to the low-afﬁnity rat nerve growth factor (NGF) receptor
(192 IgG) chemically linked to the ribosome inactivating pro-
tein saporin (192 IgG-saporin; Wiley et al., 1991) was shown
to destroy cholinergic neurons in the basal forebrain but not in
the striatum, perhaps due to the low NGF receptor expression
level in the latter cells (Book et al., 1992; Leanza et al., 1995).
A similar immunotoxin-based strategy was developed to target
striatal neurons expressing high levels of tachykinin (NK-1) recep-
tor, ablating both NPY and ChAT expressing striatal interneurons
(Saka et al., 2002).
In other experiments, neurotoxic non-selective agents were
injected in target nuclei of the striatum efferent populations (i.e.,
the SNr or the LGP) to selectively kill the striatonigral or the stri-
atopallidal neurons by axonal transport (Harrison et al., 1990;
Hervé et al., 1993; Roberts et al., 1993). While this strategy can
lead to modest reduction of striatopallidal or striatonigral neuron
number (Roberts et al., 1993), it lacks striatum speciﬁcity since the
neurotoxin can be axonally transported from the injection site to
multiple areas.
To target a speciﬁc neuronal population, either to ablate these
cells or to inactivate a speciﬁc gene within them, the genetic
targeting is the most promising approach given the large num-
ber of available tools (inducible systems, speciﬁc recombination)
and regulatory sequences. The ﬁrst success to target a striatal
cell population by classical additional transgenesis was obtained
by Nestler and colleagues (Chen et al., 1998) on the striaton-
igral neurons using a 1.8-kb fragment of the NSE (neuronal
speciﬁc enolase) promoter to express the tetracycline transacti-
vator (tTA) of the tetracycline (Tet) system. The Tet system is
based on two elements. On one hand, the transcriptional trans-
activator tTA (tetracycline transactivator) is under the control of
a cell-speciﬁc promoter. On the other hand, the gene necessary
to affect the target neuronal population is under the control of
the TRE (tetracycline-responsive element) promoter that binds
tTA and will be, therefore, regulated by the presence or absence
of tetracycline (Gossen and Bujard, 2002). Despite the fact that
NSE is not speciﬁcally expressed in striatonigral neurons, 1 the
12 lines obtained, the line A, expressed tTA in these neurons. The
speciﬁcity of this cell expression pattern is due to the insertion
site of the transgene in the genome. Using this transgenic line,
Nestler and colleagues have demonstrated that overexpression of
the transcription factor FosB in striatonigral neurons increases
the responsiveness of mice to the rewarding effect of cocaine
(Kelz et al., 1999; Colby et al., 2003) as well as the rewarding
effect and physical dependence to morphine (Zachariou et al.,
2006).
The second striatal cell population successfully targeted by clas-
sical additional transgenesis were the cholinergic interneurons.
Nakanishi and colleagues ablated themby immunotoxin-mediated
cell targeting (IMTC) which allows a conditional and time con-
trolled destruction of neurons (Kaneko et al., 2000). A transgene
was made containing the alpha subunit of human interleukin-2
receptor (hIL-2Rα) under the control of the mouse 18.3 kb 5′-
upstream genomic sequence containing the ﬁrst and second exons
of the mGluR2 gene. Out of the 14 transgenic lines obtained,
two lines (IG16 and IG17) expressed hIL-2Rα speciﬁcally in stri-
atal cholinergic interneurons (Kaneko et al., 2000). The ablation
of these cholinergic interneurons was achieved by means of the
stereotaxic injection of a monoclonal antibody against hIL-2Rα
fused with a truncated Pseudomonas exotoxin. The study of these
mice unraveled the concerted and adapted interactions between
acetylcholine and dopamine transmissions in the basal ganglia
during motor behavior (Kaneko et al., 2000) the cocaine-elicited
behavior (Hikida et al., 2001) and procedural learning (Kitabatake
et al., 2003).
KNOCK-IN STRATEGIES
The most accurate method to preserve all regulatory elements
and sequences allowing the exact spatial–temporal expression of
a gene is to insert a transgene into the native locus of the gene
of interest by homologous recombination (Knock-in). Again, the
ﬁrst population targeted by this method were the striatonigral
neurons. A transgene composed of a LoxP-NEO/STOP-LoxP cas-
sette and the diphtheria toxin A-chain gene was inserted into the
drd1a gene (Drago et al., 1998). After crossing these knock-in mice
with EIIa/Cre mice, expressing Cre recombinase in the fertilized
oocyte, the resulting pups express the diphtheria toxin A-chain
under the control of drd1a promoter. Although most pups died
in the ﬁrst postnatal week, some mice survived to P19 and dis-
played bradykinesia, dystonia and reduced striatal volume. These
mice did not express D1R, substance P and dynorphin mRNAs
in the striatum but had normal levels of D2R and enkephalin
mRNAs (Drago et al., 1998). To circumvent the short lifespan
and potential developmental compensation of these mice, Drago
and colleagues (Gantois et al., 2007) crossed the knock-in mice
with calcium/calmodulin-dependent protein kinase II a/Cre mice
(Casanova et al., 2001). The resulting mice express Cre in the fore-
brain starting from 1 to 2 weeks after birth. These mice are viable
and displayed, among other, hindlimb dystonia and locomotor
hyperactivity. An important limitation of these mice to decipher
the role of the striatonigral neurons results from the destruction
of other populations of neurons expressing drd1a in the forebrain
(Weiner et al., 1991).
Palmiter’s group targeted the expression of Cre recombinase in
drd1a neurons by a knock-in strategy by insertion in the drd1a
loci (Heusner et al., 2008). These drd1a-Cre knock-in mice have
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been crossed with Gad1 ﬂoxed mice to selectively reduce GABA
synthesis in striatonigral neurons (Heusner et al., 2008). The
resulting mice showed altered motor skill learning in some beha-
vioral test such as rotarod (Heusner et al., 2008). Using the same
knock-in mice, this group inactivated the NR1 subunit of the glu-
tamate NMDA receptor in drd1a neurons and demonstrated the
impairment of amphetamine sensitization and conditioned place
preference (CPP) in the mutant mice (Beutler et al., 2011). To
decipher the role of these neurons in amphetamine-induced plas-
tic phenomena and to bypass the fact that drd1a gene is not only
expressed in striatonigral neurons they re-expressed NR1 selec-
tively in the drd1a neurons of the NAc by Cre/lox viral strategy.
NR1 re-expression rescued amphetamine sensitization, demon-
strating that striatonigral neurons in the NAc are sufﬁcient to
retain this behavioral effect (Beutler et al., 2011).
An IMTC (see above) of striatal drd2 neurons has been under-
taken by a knock-in strategy in drd2 loci (Sano et al., 2003). One
week after intrastriatal immunotoxin treatment and ablation of
drd2 striatal neurons, mice had spontaneous hyperactivity (Sano
et al., 2003). However, drd2 is expressed not only in striatopall-
idal neurons but also in striatal cholinergic interneurons and in
dopaminergic neurons of the SNc and VTA projecting to striatal
regions (Weiner et al., 1991). In this model, the intrastriatal injec-
tion of the immunotoxin preserved the DA neurons and destroyed
the striatopallidal neurons and cholinergic interneurons (Sano
et al., 2003).
Knock-in parvalbumin (PV)-Cre mice were generated by inser-
tion of an internal ribosome entry site (IRES)-Cre cassette 3′ to the
translational stop codon of the Pvalb locus allowing a bicistronic
translation (Hippenmeyer et al., 2005). Striatal Cre recombinase
expression in these Pvalb-IRES-Cre mice was not described (Hip-
penmeyer et al., 2005), but preliminary results obtained with a
LacZ reporter strain (Soriano, 1999) indicate a very low colocal-
ization of PV immunostaining and LacZ expression (PFD et al.,
unpublished data). More recently, Madisen et al. (2009) generated
a Pvalb-2A-Cre knock-in line with a 2A-Cre sequence (mediating
bicistronic translation in a mechanism different from the IRES)
inserted 3′ to the PV stop codon. While Pvalb-2A-Cre mice, as
compared to Pvalb-IRES-Cre mice, exhibited higher level of Cre
recombination in brain areas such as cerebral cortex or thalamus,
Cre recombination in the striatum was not investigated (Madisen
et al., 2009).
While the knock-in strategy is the best strategy to mimic the
exact expression of a gene, it has the potentially important limita-
tion that the insertion of the transgene causes the loss of one of the
two loci of the target gene. In fact, there are several reports on the
effects of drd1a or drd2 heterozygosity. For example, acoustic star-
tle reactivity (Ralph-Williams et al., 2002) and dopamine-elicited
late-phase LTP and facilitation of the LTD in the medial prefrontal
cortex are signiﬁcantly altered in drd1a +/− mice (Huang et al.,
2004). In the case of drd2, locomotor activity is determined by gene
dosage (Kelly et al., 1998) and non-selective attention is different
in drd2 +/− and drd2 +/+ mice (Vallone et al., 2002).
BAC STRATEGIES
In late 1990s, the possibility to manipulate bacterial artiﬁcial chro-
mosome (BAC) containing large fragments of genomic mouse
DNA (100–250 kb) to obtain transgenic mice allowed to combine
the advantages of classical transgenesis and Knock-in strategy
(Heintz, 2001). Firstly, the use of large genomic DNA fragments
increases the possibility to preserve the key regulatory elements
of a gene to allow an accurate expression in vivo. Secondly, BAC
constructs insert at random locations throughout the genome and
the two loci of the gene of interest are then more likely to be
preserved as compare to a knock-in approach. Thirdly, since the
site of insertion of the transgene could maintain only part of the
native expression proﬁle of the targeted gene, it is possible to select
transgenic lines that target speciﬁc cell subpopulations or selected
brain nuclei.
To target the neuronal population of the striatum the two main
transgenes used were ﬂuorescent proteins (GFP or d Tomato) and
Cre recombinase (Valjent et al., 2009; see Table 1 for the dif-
ferent cell-type targeting tools). It is worth to mention that the
ﬂuorescent proteins are mainly used to target neuronal popula-
tions in adult mice to characterize them. Thus it is important
that the regulatory sequence used in the BAC mimics the adult
in vivo expression in the transgenic mice. In contrast, for Cre
recombinase expression, transgenic mice are made for mating
with ﬂoxed mice, and the resulting mice recapitulate the com-
plete developmental proﬁle (before and after birth) of the tar-
geted gene that could be different from adult expression proﬁle
only.
MEDIUM SPINY NEURON TARGETING
BAC–EGFP for D1R- and D2R-MSN visualization
In 2003, the GENSAT project published transgenic BAC reporter
mouse lines in which the enhanced green ﬂuorescent protein
(EGFP) gene is selectively expressed in a large variety of central
nervous system cell-types including the D1R or D2R expressing
cells (drd1a-EGFP and drd2-EGFP; Gong et al., 2003). Extensive
characterization of drd1a-EGFP and drd2-EGFP lines (Bertran-
Gonzalez et al., 2008; Matamales et al., 2009) revealed that EGFP
expression patterns correlate with previous in situ hybridization
or immunohistochemical studies (Hersch et al., 1995; Le Moine
and Bloch, 1995) showing that D1R and D2R are expressed in
distinct striatal neuronal populations. In the drd1a-EGFP strain,
ﬂuorescence was restricted to the striatonigral neuron popula-
tion while both striatopallidal MSNs and cholinergic interneurons
were EGFP-positive in the drd2-EGFP mice (Bertran-Gonzalez
et al., 2008). Other reporter BAC strains were also generated
to target the striatonigral neurons as chrm4-EGFP line (Gong
et al., 2003) and the red ﬂuorophore strain drd1a-tdTomato
(Shuen et al., 2008).
These reporter mice represent a powerful tool for identi-
fying each MSN-subtype in multiple experimental paradigms
using ﬁxed tissue preparations, ﬂuorescence-activated cell sort-
ing (FACS) or ex vivo electrophysiological recordings (Day et al.,
2006, 2008; Lee et al., 2006; Lobo et al., 2006; Wang et al., 2006;
Kreitzer and Malenka, 2007; Shen et al., 2007, 2008; Bertran-
Gonzalez et al., 2008; Gertler et al., 2008; Matamales et al., 2009;
Tecuapetla et al., 2009; Grueter et al., 2010). For instance, they
allowed to show that DA depletion induces a loss of spines and
glutamatergic synapses selectively on striatopallidal neurons (Day
et al., 2006) and that striatopallidal neurons selectively express
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Table 1 | Distinct strategies to target the subpopulations of the striatum.
Classical transgenesis
or knock-in
BAC Other
D1R striatonigral neurons NSE-tTA (Chen et al., 1998) drd1a-EGFP, Chrm4-EGFP (Gong et al., 2003) Volkensin toxin (Harrison et al., 1990)
drd1a-tox176 (Drago et al., 1998) drd1a-tdTomato (Shuen et al., 2008) PPTA-tTA AAV (Hikida et al., 2010)
drd1a-Cre (Heusner et al., 2008) drd1a-Cre (YAC) (Mantamadiotis et al., 2002) pDyn-hM4D HSV (Ferguson et al., 2011)
drd1a-Cre (EY262 line) (Gong et al., 2007)
drd1a-DARPP-32/Flag (Bateup et al., 2008)
drd1a-EGFP-L10A (Heiman et al., 2008)
drd1a-iRNA (mGluR5 knock-down) (Novak
et al., 2010)
D2R striatopallidal neurons drd2-hIL-2Rα (Sano et al., 2003) drd2-EGFP (Gong et al., 2003) OX7-saporin toxin (Roberts et al., 1993)
drd2-Cre (ER44 line) (Gong et al., 2007) PPE-tTA AAV (Hikida et al., 2010)
drd2-DARPP-32/Myc (Bateup et al., 2008) pEnk-hM4D HSV (Ferguson et al., 2011)
drd2-EGFP-L10a (Heiman et al., 2008)
adora2a-Cre (Durieux et al., 2009)
ChAT interneurons mGluR2-hIL-2Rα (Kaneko et al.,
2000)
Chat -EGFP (Gong et al., 2003)
Chat -Cre (GM24 and GM60) (Gong et al.,
2007)
AF64A toxin (Mantione et al., 1981)
SP-PE35 toxin (Saka et al., 2002)
NPY-NO interneurons n/a Npy -Cre (DeFalco et al., 2001) SP-PE35 toxin (Saka et al., 2002)
Npy -Tau-Sapphire-GFP (Pinto et al., 2004;
Roseberry et al., 2004)
Npy -hrGFP (van den Pol et al., 2009)
Nos1-EGFP, Npy -Cre (RH26-CRE and
RH28-CRE) (http://www.gensat.org)
PV-interneurons Pvalb-IRES-Cre (Hippenmeyer
et al., 2005)
Pvalb-2A-Cre (Madisen et al.,
2009)
Pvalb-EGFP (Meyer et al., 2002)
Pvalb-EGFP (Gong et al., 2003)
Pvalb-Cre (Tanahira et al., 2009)
n/a
CR interneurons n/a n/a n/a
n/a: not available.
an endocannabinoid-mediated long-term depression (eCB-LTD)
that is disrupted in DA-depleted animals (Kreitzer and Malenka,
2007). Speciﬁc expression proﬁles of D1R and D2R MSNs were
determined using FACS assays coupled to microarray analysis
in drd1a-, drd2-, and chrm4-EGFP mice (Lobo et al., 2006),
identifying multiple new genes preferentially expressed in each
MSN-subtype.
Recent report pointed out major abnormalities in drd2-EGFP
mice from GENSAT (Kramer et al., 2010). Alvarez and colleagues
showed that, as compare to WT mice, drd2-EGFP mice exhibit a
D2R overexpression (i.e., increase in striatal D2R binding and D2R
mRNA levels), enhanced electrophysiological responses to D2R
activation in midbrain dopaminergic neurons as well as impaired
DA clearance after NAc stimulation or cocaine administration
(Kramer et al., 2010). Behaviorally,drd2-EGFPmice display hyper-
activity in novel environment, hypersensitivity to D2R-like ago-
nists and deﬁcient acute and chronic response to cocaine (Kramer
et al., 2010).
These results highlight the importance of extensive charac-
terization and adequate controls when using transgenic mice in
neuroscience research.
Cre BAC for manipulation of striatonigral and striatopallidal
neurons or genes to shed light on their physiological roles
The ﬁrst attempt to use a large mouse genomic fragment (140 kb)
of drd1a gene has been undertaken with a yeast artiﬁcial chro-
mosome (YAC) to unravel the role of cAMP responsive element
binding protein (CREB) and cAMP responsive element modula-
tory protein (CREM) in striatal neurodegeneration (Mantama-
diotis et al., 2002). The extensive characterization of these mice
showed that the transgene has a spatiotemporal expression pat-
tern that closely recapitulated the pattern of drd1a gene but is
expressed in most dopaminoceptive neurons of the striatum and
not only in the striatonigral neurons (Lemberger et al., 2007).
Having generated a large library of BAC–GFP mice, the
GENSAT project then proceeded to generate a BAC-Cre mice
library (Gong et al., 2007). In a ﬁrst study, Greengard and col-
leagues used the drd1a-Cre (EY262 line) and drd2-Cre (ER44
line) mice to demonstrate that deletion of the histone methy-
lase GLP/G9a led to de-repression of non-neuronal genes in
each MSN populations. The study showed an altered locomotor
response to pharmacological agents that target striatonigral and
striatopallidal neurons in the conditional KO mice (Schaefer
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et al., 2009). In a second study, they crossed the same lines
of drd1a-Cre and drd2-Cre mice with dopamine- and cAMP-
regulated phosphoprotein Mr 32 kDa (DARPP-32) ﬂoxed mice.
Striatonigral DARPP-32-deleted mice show a decrease in basal
and cocaine-induced locomotion and an abolition of l-DOPA-
induced dyskinesia. Conversely, striatopallidal DARP32-deleted
mice have increased locomotor activity and reduced haloperidol-
induced catalepsy (Bateup et al., 2010). In this last study, they
clearly showed that the deletions of DARPP-32 in striatonigral
or striatopallidal neurons are speciﬁc. However, since DARPP-
32 is only expressed in MSNs, these experiments do not rule
out that, drd2-Cre mice, Cre recombinase is also expressed in
cholinergic interneurons and/orDAneurons as shown forD2-GFP
(Matamales et al., 2009).
Inparallelwith theGENSATBAC-Cre,other striatopallidal-Cre
mice have been developed by choosing the adora2a gene (adeno-
sine A2A receptor) which is expressed in striatopallidal neurons
but not in other striatal neuronal populations or in the presy-
naptic DA neurons (Durieux et al., 2009). The characterization
of mice resulting from the crossing between adora2a-Cre mice
and inducible diphtheria toxin receptor (iDTR) mice (Buch et al.,
2005) after striatal diphtheria toxin injection have demonstrated
that only striatopallidal neurons were targeted. The resulting
mice show an increase in spontaneous locomotor activity after
a whole striatum striatopallidal neuron ablation and an increase
of amphetamine CPP after ventral striatum striatopallidal neuron
ablation, thus demonstrating the in vivo roles of striatopallidal
neurons in both locomotion and drug reinforcement inhibition
(Durieux et al., 2009).
Themost recent advances in this domain have been obtained by
combining BAC-Cre expressing mice with optogenetics, allowing
control of neuron-type activity with high temporal and spatial res-
olutions (Kravitz et al., 2010; Lobo et al., 2010). In this paradigm,
two types of membrane light-sensitive proteins are used to respec-
tively activate or silence neurons: the channelrhodopsin-2 (ChR2)
cation channel and the halorhodopsin (NpHR) chloride pump
respectively (Boyden et al., 2005; Zhang et al., 2007). Blue light
induces a conformational change that opens ChR2 pore which
rapidly and reversibly depolarizes the cell membrane and triggers
action potentials (Boyden et al., 2005), while yellow light acti-
vates NpHR,which generates a chloride ﬂow and causes rapid and
reversible cell membrane hyperpolarization that prevents action
potentials (Zhang et al., 2007).
Stereotactic injections of Cre-dependent ChR2 orNpHR adeno
associated virus (AAV) in Cre lines lead to cell-type speciﬁc
expressions of the light-sensitive proteins and optical stimulation
is applied locally, through an optical ﬁber coupled to a diode
laser, inserted in the brain area of interest (Sohal et al., 2009;
Carter et al., 2010).
A ﬁrst study using striatal BAC-Cre strains has demon-
strated that bilateral excitation of dorsomedial striatal neurons
of drd1a-Cre mice injected with AAV-DIO-ChR2-YFP (in which
Cre-dependent expression of ChR2 is coupled to the yellow ﬂu-
orescent protein, YFP) causes reduced freezing and increased
locomotion (Kravitz et al., 2010). The same dorsomedial neuron
excitation of drd2-Cre mice injected with AAV-DIO-ChR2-YFP
increases freezing, and bradykinesia, and decreases locomotor
initiation. In a mouse model of Parkinson’s disease (injection of
6-hydroxydopamine in dorsomedial striatum), dorsomedial exci-
tation of striatonigral neurons rescued these deﬁcits (Kravitz et al.,
2010). They showed that the AAV recombined mainly in striatoni-
gral and striatopallidal neurons, respectively, by demonstrating the
presence of YFP staining in the targets nuclei of the two neuronal
populations (SNr and GP, respectively). However, they did not
specify which drd1a-Cre (EY217, EY242, EY262, EY266, FK150,
and FK164) and drd2-Cre (ER43 and ER44) GENSAT lines were
used and this could be of importance because the Cre expres-
sion proﬁles are different in these lines. Yet, some striatal PV
and NPY interneurons are also targeted in drd1a-Cre and ChAT
interneurons are targeted in drd2-Cre mice (Kravitz et al., 2010).
Finally, DA neurons are not targeted in drd2-Cre mice by these
stereotaxic injections of AAV-DIO-ChR2-YFP in the dorsomedial
striatum.
The second optogenetic study using also the drd1a-Cre and
drd2-CreGENSATmice andAAV-DIO-ChR2-YFP, targets theNAc
to unravel the role of direct and indirect pathways (Lobo et al.,
2010). Illumination of NAc neurons in drd2-Cre mice injected
with AAV-DIO-ChR2-YFP suppresses cocaine reward whereas the
opposite effect is found by illumination of the neurons in the
NAc of drd1a-Cre mice injected with AAV-DIO-ChR2-YFP (Lobo
et al., 2010). These resultsmimic those obtained inTrkb (the brain-
derived neurotrophic factor receptor) ﬂoxed mice with the same
drd2-Cre and drd1a-Cre mice (Lobo et al., 2010).
It is important to conclude by noting that currently GENSAT
offers six different drd1a-Cre lines and two drd2-Cre lines1 with
variable Cre recombinase expression proﬁle that potentially allow
to target different populations and subregions in the striatum.
It is worth also to note that the Cre recombinase expression in
the BAC-Cre mice is generally evaluated by crossing them with
reporter strains as Rosa26 Lox-Stop-Lox EGFP; meaning that only
the spatiotemporal proﬁle of the Cre recombinase can be deduced
and not its the level of expression.
Others transgene-BAC
drd1a and drd2 BAC have been used to express other trans-
genes than eGFP and Cre recombinase. Indeed, to unravel the
speciﬁc role of DARPP-32 in striatonigral and striatopallidal neu-
rons Greengard and colleagues have generated two different BAC
transgenic mice: one containing a bicistronic transgene composed
of a C-terminal Flag-tagged DARPP-32 and a Venus ﬂuorescent
protein under the control of the drd1a promoter on a BAC
and the other containing the bicistronic transgene composed of
a C-terminal Myc-tagged DARPP-32 and enhanced cyan ﬂuo-
rescent protein (Bateup et al., 2008). Characterization of these
two transgenic mice show that 36.7% of striatal cells expressed
GFP mRNA in drd1a-DARPP-32/Flag mice and 41.4% in drd2-
DARPP-32/Myc mice and that the expression is speciﬁc to stri-
atonigral or striatopallidal neurons, respectively (Bateup et al.,
2008). These transgenic mice have allowed to demonstrate that
cocaine increases T-34 phosphorylation of DARPP-32 speciﬁ-
cally in striatonigral neurons whereas haloperidol induces the
1http://www.gensat.org/cre.jsp
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same type of phosphorylation selectively in striatopallidal neurons
(Bateup et al., 2008).
Greengard, Heintz, and colleagues have also generated two
other mouse lines with drd1a or drd2 BAC that allow to purify
polysomal mRNAs of speciﬁc neuronal populations to identify
molecular changes in normal condition or after cocaine injection
(Heiman et al., 2008). With this purpose, a fusion of EGFP to
the N terminal of the large subunit ribosomal protein L10a was
inserted under the control of the promoter of either drd1a or
drd2 in an appropriate BAC. The drd1a-EGFP-L10a line (CP73)
showed expression of EGFP in the dorsal and ventral striatum,
olfactory bulb, olfactory tubercle, and cortical layers ﬁve and six.
The drd2-EGFP-L10a line (CP101) showed expression of EGFP
in the dorsal and ventral striatum, olfactory tubercle, and hip-
pocampus, as well as in the substantia nigra pars compacta and
ventral tegmental area. Enkephalin immunostaining in the stria-
tum colocalized with EGFP in drd2-EGFP-L10a mice but not in
drd1a-EGFP-L10a. Polysomal mRNAs of isolated and homog-
enized striata were immunoprecipitated with magnetic beads
coatedwith an antibody against EGFP on each of this two lines and
translational proﬁling was determined by microarrays. Around 70
additional striatopallidal-enriched transcripts and more than 150
additional striatonigral-enriched transcripts with respect to the
FACS-isolatedMSNstudy (Lobo et al.,2006)were identiﬁedby this
method (Heiman et al., 2008). The same analysis was performed
after acute or chronic cocaine injection and hundreds of genes
whose expressionwas increased or decreased in each cell-typewere
identiﬁed (Heiman et al., 2008).
Another study has used a drd1a BAC to express a short hairpin
RNA to knock-down mGluR5 (Novak et al., 2010). GFP was intro-
duced in tandem with two microRNAs against mGluR5 to track
the expression of the sh-RNA. The GFP was expressed in 53% of
striatal neurons that correspond toDARPP-32 neurons that do not
express enkephalin, thus striatonigral neurons as expected (Novak
et al., 2010). Moreover, the mRNA level of mGluR5 decreases
signiﬁcantly only in the striatum. These transgenic mice show
impairment in the reinstatement of cocaine-seeking induced by
a cocaine-paired stimulus due to a deﬁcit in speciﬁc incentive
learning processes (Novak et al., 2010).
TARGETING OF STRIATAL INTERNEURONS
GENSAT project generated choline acetyltransferase (ChAT)-
EGFP (Gong et al., 2003) and ChAT-Cre (Gong et al., 2007) mice.
Two Chat BAC-Cre transgenic lines (GM24 and GM60) showed
brain Cre recombination that matched the expression of Chat in
the adult, while the GM53 founder exhibited Cre recombination
only in brainstem and spinal cord motor neurons (see text foot-
note 1). The GM24 strain was recently used in an optogenetic
paradigm showing that ChAT interneurons in the NAc could be
activated by cocaine and that silencing this drug-induced activ-
ity during cocaine exposure disrupted cocaine place preference
conditioning (Witten et al., 2010).
Enhanced green ﬂuorescent protein expression in parvalbumin
(PV) interneurons of the striatum was initially obtained in a BAC
line (Pvalb-EGFP; Meyer et al., 2002) with 96% of colocalization,
calculated as the number of EGFP-positive cells stained with PV
antibody. Using these Pvalb-EGFP mice, Freiman et al. (2006)
found that activation of CB1 cannabinoid receptors led to presy-
naptic inhibition of PV-interneurons to MSN neurotransmission.
Pvalb-EGFP mice were also developed by the GENSAT project
(Gong et al., 2003) in which EGFP detection in the striatum seems
to match the endogenous pattern of Pvalb expression but was not
extensively characterized.
A Pvalb-Cre BAC strain, with a Cre recombinase DNA inserted
into the Pvalb start codon,was generated by Tanahira et al. (2009),
in which the Cre expression seems to match the PV expression
in basal ganglia, including the caudate nucleus and the putamen
(determined by Cre and PV double immunohistochemistry).
Npy-Cre BAC mice were generated by Friedman and colleagues
at the Rockefeller University (DeFalco et al., 2001) to trace hypo-
thalamic NPY neuron connections after stereotactic injection of
a Cre-dependent GFP virus. Extensive characterization of Cre
expression with a reporter strain was not performed in these mice
and, notably, presence of Cre recombinase in the striatum remains
elusive. Recently, the GENSAT project generated Npy-Cre mice
(founders RH26-CRE and RH28-CRE) exhibiting a Cre expres-
sion pattern spatially similar to NPY (see text footnote 1) but Cre
and NPY colocalization needs to be performed in these mice.
Friedman’s laboratory also developed Npy-Tau-Sapphire-GFP
BAC mice to investigate functions of NPY-positive neurons in
the arcuate nucleus of the hypothalamus (Pinto et al., 2004; Rose-
berry et al., 2004). Unfortunately, theGFP expression in thesemice
appeared lower than revealed by histochemistry (van den Pol et al.,
2009), and recent study showed morphological and electrophys-
iological pathological abnormalities in Npy-Tau-Sapphire-GFP
interneurons compared with WT NPY interneurons that could
be due to the overexpression of tau-coupled reporter constructs
(Rancillac et al., 2010). Another group generated a BAC Npy-
human codon corrected Renilla (hr)-GFP transgenic mice, with
a GFP from a type of soft coral (sea pansy Renilla) that seems to
be more stable and brighter than other green ﬂuorescent protein
(van den Pol et al., 2009). In these Npy-hrGFP mice, the caudate–
putamen and the NAc contained scattered intensely GFP-positive
cells (van den Pol et al., 2009) and colocalization of NPY and
GFP in the striatum was conﬁrmed by Partridge et al. (2009) that
used these mice to specify properties of synaptic connections onto
striatal NPY interneurons.
Finally, the GENSAT project also generated BAC lines in
which GFP is under control of the neuronal nitric oxide synthase
(nNOS) promoter (Nos1)2. However, none of theNos1-EGFP lines
generated show EGFP in striatal nNOS interneurons.
To date, to the best of our knowledge, no genetic tool has
been developed to target selectively the striatal calretinin-positive
interneurons.
VIRAL TARGETING
Recently, two papers have targeted striatonigral and striatopal-
lidal neurons in mice and rats by using viral vectors (Hikida
et al., 2010; Ferguson et al., 2011). To target mice striatonigral
neurons, the −1525 to +543 residues of the mouse PPTA gene
(Substance P) have been inserted in front of Flag-tagged tTA in
2http://www.gensat.org
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an AAV vector whereas the −1834 to +148 residues of the mouse
Penk gene (Enkephalin) have been used to target the striatopall-
idal neurons (Hikida et al., 2010). The AAVs have been injected
in transgenic mice (TN) containing the TRE–GFP-tetanus toxin
transgene allowing that cause the inhibition of neurotransmission
in neurons expressing tTA when doxycycline is withdrawn. The
TN mice bilaterally injected into 11 sites of the striatum withAAV-
PPTA-tTA showed an exclusive GFP immunostaining in 74.2% of
SP-positive cells whereas in TN mice injected with AAV-PPE-tTA
71.1% of ENK-containing neurons were immunostained by GFP,
demonstrating a speciﬁc targeting of striatonigral and striatopalli-
dal neurons, respectively (Hikida et al., 2010). Surprisingly, despite
these percentage of targeted neurons targeted in either direct or
indirect pathways whose neurotransmission was abolished, the
resulting mice did not show a decrease or increase of sponta-
neous locomotor activity (Hikida et al., 2010) in contrast to the
results obtained with BAC (Durieux et al., 2009; Bateup et al.,
2010; Kravitz et al., 2010). TN mice bilaterally injected into four
sites of the NAc with the transgenic AAV that results in the block-
ade of the direct pathway showed a decrease in cocaine-induced
CPP (Hikida et al., 2010) in accordance with the results obtained
in BAC mice using optogenetic approaches (Lobo et al., 2010). No
difference in cocaine-induced CCP was found when the indirect
pathway was inhibited (Hikida et al., 2010) in contrast with the
results obtained with BAC technology (Durieux et al., 2009; Lobo
et al., 2010). These differences could be explained by the different
proportion of neurons that were targeted by the two approaches.
In rats, the availability of transgenic tools is much more limited
than in mice. A very recent study reports the genetic targeting of
both MSN populations. The −2609 to +52 residues of the rat Penk
gene (Enkephalin) and the −1858 to +135 residues of the rat Pdyn
gene (Dynorphin) were inserted in herpes simplex virus (HSV)
in front of an hemagglutinin-tagged engineered GPCR (derived
from the Gi/o-coupled human muscarinic M4, hM4D, activated
by an inert ligand, CNO; Ferguson et al., 2011). Administration of
CNO induced the activation of Kir3 channel in neurons expressing
hM4D, resulting in membrane hyperpolarization, and transient
neuronal silencing. In rats infused into one site of the dorsal
striatum with pEnk-hM4D HSV, 90% of hemagglutinin cells were
Enk-positive and 6% were SP-positive whereas with pDyn-hM4D
HSV 95% of hemagglutinin cells were substance P positive and 5%
were Enk-positive (Ferguson et al., 2011). The percentage of Enk-
or SP- positive neurons infected in the dorsal striatum by these
HSV vectors was unknown. CNO treatment decreased the num-
ber of evoked action potentials in hM4D-expressing neurons. In
pEnk- hM4D rats, CNO treatment facilitated the development of
a robust amphetamine sensitization in contrast with pDyn- hM4D
rats (Ferguson et al., 2011).
CONCLUSION AND PERSPECTIVES
The recent advances in genetic targeting have allowed to address
a lot of important physiological issues in the striatum which
were unattainable in the past. However each of these approaches
(Knock-in, BAC, Virus. . .) needs an extensive characterization of
the resulting transgenic mice to avoid some overstated conclu-
sions. The optogenetics by its ﬂexibility and its time resolution
will certainly allow to solve new important questions in striatal
physiology. Moreover, a very recent advance in optogenetic tools
(Ye et al., 2011) has demonstrated the possibility to control tran-
scription of speciﬁc transgenes by light. This additional progress
will allow not only to control the activity of a neuronal population
but also to control the expression of a speciﬁc gene in this neu-
ronal population. A next important step will be to export all these
tools to other models than mouse, as rat and monkey, where more
elaborated behavioral paradigms are possible.
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